ccopy_reg
_reconstructor
p1
(ctethne.classes.paper
Paper
p2
c__builtin__
object
p3
NtRp4
(dp5
S'publisherCity'
p6
VROCKVILLE
p7
sS'reprintAddress'
p8
VVan Damme, EJM (reprint author), Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium.
p9
sS'WC'
p10
VPlant Sciences
p11
sS'GA'
p12
V727ZY
p13
sS'FX'
p14
(lp15
VThis work was supported by the Institute for the Promotion of Innovation
p16
aVthrough Science and Technology in Flanders (grant no. SB/73164/Nagels).
p17
asS'abstract'
p18
VIn recent years, plants have been developed as an alternative expression system to mammalian hosts for the production of therapeutic proteins. Many modifications to the plant glycosylation machinery have been made to render it more human because of the importance of glycosylation for functionality, serum half-life, and the safety profile of the expressed proteins. These modifications include removal of plant-specific beta 1,2-xylose and core alpha 1,3-fucose, and addition of bisecting N-acetylglucosamine, beta 1,4-galactoses, and sialic acid residues. Another glycosylation step that is essential for the production of complex human-type glycans is the synthesis of multiantennary structures, which are frequently found on human N-glycans but are not generated by wild-type plants. Here, we report both the magnICON-based transient as well as stable introduction of the alpha 1,3-mannosyl-beta 1,4-N-acetylglucosaminyltransferase (GnT-IV isozymes a and b) and alpha 1,6-mannosyl-beta 1,6-N-acetylglucosaminyltransferase (GnT-V) in Nicotiana benthamiana plants. The enzymes were targeted to the Golgi apparatus by fusing their catalytic domains to the plant-specific localization signals of xylosyltransferase and fucosyltransferase. The GnT-IV and -V modifications were tested in the wild-type background, but were also combined with the RNA interference-mediated knockdown of beta 1,2-xylosyltransferase and alpha 1,3-fucosyltransferase. Results showed that triantennary Gn[GnGn] and [GnGn]Gn N-glycans could be produced according to the expected activities of the respective enzymes. Combination of the two enzymes by crossing stably transformed GnT-IV and GnT-V plants showed that up to 10% tetraantennary [GnGn][GnGn], 25% triantennary, and 35% biantennary N-glycans were synthesized. All transgenic plants were viable and showed no aberrant phenotype under standard growth conditions.
p19
sS'pageEnd'
p20
I1112
sS'date'
p21
I2011
sS'documentType'
p22
VArticle
p23
sS'subject'
p24
VPlant Sciences
p25
sS'isoSource'
p26
VPlant Physiol.
p27
sS'timesCited'
p28
(lp29
I11
aVZ9 11
p30
asS'funding'
p31
(lp32
(VInstitute for the Promotion of Innovation through Science and Technology in Flanders
VSB/73164/Nagels
tp33
asS'PT'
p34
VJ
sS'title'
p35
VProduction Of Complex Multiantennary N-Glycans In Nicotiana Benthamiana Plants
p36
sS'ISSN'
p37
(lp38
V0032-0889
p39
aVJ9 PLANT PHYSIOL
p40
asS'authors_full'
p41
(lp42
(VNAGELS
VBIEKE
tp43
a(VVAN DAMME
VELS J M
tp44
a(VPABST
VMARTIN
tp45
a(VCALLEWAERT
VNICO
tp46
a(VWETERINGS
VKOEN
tp47
asS'PG'
p48
I10
sS'PD'
p49
VMAR
p50
sS'pageStart'
p51
I1103
sS'issue'
p52
I3
sS'journal'
p53
VPLANT PHYSIOLOGY
p54
sS'volume'
p55
V155
p56
sS'doi'
p57
V10.1104/pp.110.168773
p58
sS'emailAddress'
p59
Velsjm.vandamme@ugent.be
p60
sS'authorAddress'
p61
(lp62
V[Nagels, Bieke; Van Damme, Els J. M.] Univ Ghent, Fac Biosci Engn, Dept Mol Biotechnol, Lab Biochem & Glycobiol, B-9000 Ghent, Belgium.
p63
aV[Nagels, Bieke; Weterings, Koen] Bayer BioSci NV, B-9052 Ghent, Belgium.
p64
aV[Pabst, Martin] Univ Nat Resources & Appl Life Sci, Dept Chem, A-1190 Vienna, Austria.
p65
aV[Callewaert, Nico] VIB, Dept Mol Biomed Res, Unit Med Biotechnol, B-9052 Ghent, Belgium.
p66
aV[Callewaert, Nico] Univ Ghent, Fac Sci, Dept Biochem & Microbiol, B-9052 Ghent, Belgium.
p67
asS'publisherAddress'
p68
V15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA
p69
sS'ER'
p70
V
sS'publisher'
p71
VAMER SOC PLANT BIOLOGISTS
p72
sS'authorKeywords'
p73
(lp74
VGLYCOSYLATION PATTERNS
p75
aVLINKED GLYCOSYLATION
p76
aVEXPRESSION
p77
aVANTIBODY
p78
aVBETA-1,4-GALACTOSYLTRANSFERASE
p79
aVGENERATION
p80
aVFUCOSE
p81
aVTIME
p82
asS'language'
p83
VEnglish
p84
sS'wosid'
p85
VWOS:000287843800006
p86
sS'citationCount'
p87
I30
sS'authors_init'
p88
(lp89
(VNAGELS
VB
tp90
a(VVAN DAMME
VE J M
tp91
a(VPABST
VM
tp92
a(VCALLEWAERT
VN
tp93
a(VWETERINGS
VK
tp94
asS'citedReferences'
p95
(lp96
g1
(g2
g3
NtRp97
(dp98
g57
V10.1073/pnas.0600879103
p99
sg53
VP NATL ACAD SCI USA
p100
sg55
V103
p101
sg88
(lp102
(VBAKKER
VH
tp103
asg21
I2006
sg51
V7577
p104
sbag1
(g2
g3
NtRp105
(dp106
g57
V10.1073/pnas.031419998
p107
sg53
VP NATL ACAD SCI USA
p108
sg55
V98
p109
sg88
(lp110
(VBAKKER
VH
tp111
asg21
I2001
sg51
V2899
p112
sbag1
(g2
g3
NtRp113
(dp114
g57
V10.1105/tpc.12.11.2201
p115
sg53
VPLANT CELL
p116
sg55
V12
p117
sg88
(lp118
(VBATOKO
VH
tp119
asg21
I2000
sg51
VLANT
p120
sbag1
(g2
g3
NtRp121
(dp122
g57
V10.1093/glycob/cwg040
p123
sg53
VGLYCOBIOLOGY
p124
sg55
V13
p125
sg88
(lp126
(VCALLEWAERT
VN
tp127
asg21
I2003
sg51
V367
p128
sbag1
(g2
g3
NtRp129
(dp130
g57
V10.1074/jbc.M109.088401
p131
sg53
VJ BIOL CHEM
p132
sg55
V285
p133
sg88
(lp134
(VCASTILHO
VA
tp135
asg21
I2010
sg51
V15923
p136
sbag1
(g2
g3
NtRp137
(dp138
g57
V10.1073/pnas.0931263100
p139
sg53
VP NATL ACAD SCI USA
p140
sg55
V100
p141
sg88
(lp142
(VCHOI
VB K
tp143
asg21
I2003
sg51
V5022
p144
sbag1
(g2
g3
NtRp145
(dp146
g57
V10.1038/nbt1260
p147
sg53
VNAT BIOTECHNOL
p148
sg55
V24
p149
sg88
(lp150
(VCOX
VK M
tp151
asg21
I2006
sg51
V1591
p152
sbag1
(g2
g3
NtRp153
(dp154
g57
V10.1054/bjoc.2001.1746
p155
sg53
VBRIT J CANCER
p156
sg55
V84
p157
sg88
(lp158
(VEGRIE
VJ C
tp159
asg21
I2001
sg51
V3
sbag1
(g2
g3
NtRp160
(dp161
g57
V10.1111/j.1467-7652.2009.00497.x
p162
sg53
VPLANT BIOTECHNOL J
p163
sg55
V8
sg88
(lp164
(VGOMORD
VV
tp165
asg21
I2010
sg51
VLANT
p166
sbag1
(g2
g3
NtRp167
(dp168
g57
V10.1111/j.1467-7652.2004.00062.x
p169
sg53
VPlant Biotechnol J
p170
sg55
V2
sg88
(lp171
(VGOMORD
VVE\u0301RONIQUE
tp172
asg21
I2004
sg51
Vlant
p173
sbag1
(g2
g3
NtRp174
(dp175
g57
V10.1016/S0014-5793(03)01234-1
p176
sg53
VFEBS LETT
p177
sg55
V554
p178
sg88
(lp179
(VKANEKO
VM
tp180
asg21
I2003
sg51
V515
p181
sbag1
(g2
g3
NtRp182
(dp183
g57
V10.1111/j.1467-7652.2004.00100.x
p184
sg53
VPLANT BIOTECHNOL J
p185
sg55
V2
sg88
(lp186
(VKOPRIVOVA
VA
tp187
asg21
I2004
sg51
VLANT
p188
sbag1
(g2
g3
NtRp189
(dp190
g57
V10.1093/glycob/11.3.175
p191
sg53
VGLYCOBIOLOGY
p192
sg55
V11
p193
sg88
(lp194
(VLAROY
VW
tp195
asg21
I2001
sg51
V175
p196
sbag1
(g2
g3
NtRp197
(dp198
g57
V10.1006/meth.2001.1262
p199
sg53
VMETHODS
p200
sg55
V25
p201
sg88
(lp202
(VLIVAK
VK J
tp203
asg21
I2001
sg51
V402
p204
sbag1
(g2
g3
NtRp205
(dp206
g57
V10.1038/nbt1094
p207
sg53
VNAT BIOTECHNOL
p208
sg55
V23
p209
sg88
(lp210
(VMARILLONNET
VS
tp211
asg21
I2005
sg51
V718
p212
sbag1
(g2
g3
NtRp213
(dp214
g57
Nsg53
VJ BIOL CHEM
p215
sg55
V246
p216
sg88
(lp217
(VMORELL
VA G
tp218
asg21
I1971
sg51
V1461
p219
sbag1
(g2
g3
NtRp220
(dp221
g57
V10.1021/ac070363i
p222
sg53
VANAL CHEM
p223
sg55
V79
p224
sg88
(lp225
(VPABST
VM
tp226
asg21
I2007
sg51
V5051
p227
sbag1
(g2
g3
NtRp228
(dp229
g57
V10.1073/pnas.96.8.4692
p230
sg53
VP NATL ACAD SCI USA
p231
sg55
V96
p232
sg88
(lp233
(VPALACPAC
VN Q
tp234
asg21
I1999
sg51
V4692
p235
sbag1
(g2
g3
NtRp236
(dp237
g57
V10.1016/j.coi.2008.06.007
p238
sg53
VCURR OPIN IMMUNOL
p239
sg55
V20
p240
sg88
(lp241
(VRAJU
VT S
tp242
asg21
I2008
sg51
V471
p243
sbag1
(g2
g3
NtRp244
(dp245
g57
V10.1038/nbt0210-107
p246
sg53
VNAT BIOTECHNOL
p247
sg55
V28
p248
sg88
(lp249
(VRATNER
VM
tp250
asg21
I2010
sg51
V107
p251
sbag1
(g2
g3
NtRp252
(dp253
g57
Nsg53
VPLANT CELL REP
p254
sg55
V11
p255
sg88
(lp256
(VREGNER
VF
tp257
asg21
I1992
sg51
VLANT
p258
sbag1
(g2
g3
NtRp259
(dp260
g57
V10.1093/glycob/cwl078
p261
sg53
VGLYCOBIOLOGY
p262
sg55
V17
p263
sg88
(lp264
(VROUWENDAL
VG J A
tp265
asg21
I2007
sg51
V334
p266
sbag1
(g2
g3
NtRp267
(dp268
g57
V10.1105/tpc.105.036400
p269
sg53
VPLANT CELL
p270
sg55
V18
p271
sg88
(lp272
(VSAINT-JORE-DUPAS
VC
tp273
asg21
I2006
sg51
VLANT
p274
sbag1
(g2
g3
NtRp275
(dp276
g57
V10.1016/j.tibtech.2007.04.008
p277
sg53
VTRENDS BIOTECHNOL
p278
sg55
V25
p279
sg88
(lp280
(VSAINT-JORE-DUPAS
VC
tp281
asg21
I2007
sg51
V317
p282
sbag1
(g2
g3
NtRp283
(dp284
g57
V10.1074/jbc.M202069200
p285
sg53
VJ BIOL CHEM
p286
sg55
V277
p287
sg88
(lp288
(VSHIELDS
VR L
tp289
asg21
I2002
sg51
V26733
p290
sbag1
(g2
g3
NtRp291
(dp292
g57
Nsg53
VPHYSIOL REV
p293
sg55
V75
p294
sg88
(lp295
(VSTOCKERT
VR J
tp296
asg21
I1995
sg51
VHYSIOL
p297
sbag1
(g2
g3
NtRp298
(dp299
g57
V10.1016/S0014-5793(04)00150-4
p300
sg53
VFEBS LETT
p301
sg55
V561
p302
sg88
(lp303
(VSTRASSER
VR
tp304
asg21
I2004
sg51
V132
p305
sbag1
(g2
g3
NtRp306
(dp307
g57
V10.1111/j.1467-7652.2008.00330.x
p308
sg53
VPLANT BIOTECHNOL J
p309
sg55
V6
sg88
(lp310
(VSTRASSER
VR
tp311
asg21
I2008
sg51
VLANT
p312
sbag1
(g2
g3
NtRp313
(dp314
g57
V10.1016/j.tibtech.2003.10.002
p315
sg53
VTRENDS BIOTECHNOL
p316
sg55
V21
p317
sg88
(lp318
(VTWYMAN
VR M
tp319
asg21
I2003
sg51
V570
p320
sbag1
(g2
g3
NtRp321
(dp322
g57
V10.1023/A:1006951519522
p323
sg53
VGLYCOCONJUGATE J
p324
sg55
V15
p325
sg88
(lp326
(VYOSHIDA
VA
tp327
asg21
I1998
sg51
V1115
p328
sbasb.